HNB
ANAB icon

Huntington National Bank’s AnaptysBio ANAB Stock Holding History

Huntington National Bank’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$3.35K – 4157
2024
Q3 		$3.35K Hold
100
– – ﹤0.01% 2103
2024
Q2 		$2.51K Hold
100
– – ﹤0.01% 2100
2024
Q1 		$2.25K Buy
+100
New +$2.37K ﹤0.01% 2110

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Huntington National Bank's ANAB Position: Q4 2024 in Review

Huntington National Bank sold out of AnaptysBio (ANAB) in Q4 2024, closing a stake of 100 shares — an estimated $3.35K sold.

Huntington National Bank first reported a position in ANAB in Q1 2024 and held it in 3 quarters. The position peaked at $3.35K in Q3 2024. 135 funds tracked by Wall St. Rank hold ANAB as of Q4 2024.

  • Huntington National Bank reported no remaining AnaptysBio position as of Q4 2024 after selling out during the quarter.
  • Huntington National Bank sold 100 AnaptysBio shares in Q4 2024, an estimated $3.35K.
  • Huntington National Bank first reported a position in AnaptysBio in Q1 2024 and held it in 3 quarters.
  • Huntington National Bank's AnaptysBio position peaked at $3.35K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2024.

Based on Huntington National Bank's 13F filing for Q4 2024, filed 12 Feb 2025.